Clarivate Completes $600 Million Sale of Life Sciences & Healthcare Segment

MT newswire2026/10/06 20:51

04:51 PM EDT, 10/06/2026 (MT Newswires) -- Clarivate (CLVT) said Tuesday it completed the sale of its Life Sciences & Healthcare segment to Altaris for $600 million. The deal will sharpen Clarivate's focus on its Academia & Government and Intellectual Property segments. Clarivate said that, as previously announced, it will use the transaction proceeds to reduce debt and strengthen its balance sheet.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Toyota to Re-import US-made Camry Cars into Japan in Late November

智通财经•2026/11/09 09:25

Spot platinum breaks above $1,550 per ounce, up 1.21% intraday

智通财经•2026/11/09 09:15

Russia seizes Japan Tobacco assets, potentially impacting Japanese government dividend income

智通财经•2026/11/09 09:06

SoftBank Quarterly Preview: Net Interest-Bearing Debt Rises to 10.8 Trillion Yen

智通财经•2026/11/09 08:31